Peter Ricci Pellegrino

Peter Ricci Pellegrino

Auto-generated profile, based on publicly available information

Peter Ricci Pellegrino

Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE 68198

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2022 in Heliyon
Verified
Journal Article
Open access
ZXZhiqiu Xia
Zhiqiu Xia
LHLi Han
Li Han
PPPeter R. Pellegrino
Peter R. Pellegrino
ASAlicia Schiller
Alicia Schiller
LHLogan D. Harrold
Logan D. Harrold
HWHANJUN WANG
HANJUN WANG
A systematic analysis of clinical trials was performed in order to assess the effectiveness and risks of bilateral renal denervation (RDN) in patients with chronic heart failure with reduced ejection fraction (HFrEF). A systematic review was conducted of all clinical trials exploring the effectiveness of RDN in patients with HF who had reduced (<50%) EF. Primary outcomes were NYHA class, 6-min walk test, N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels, left ventricular ejection fraction (LVEF) and other cardiac parameters including left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic diameter (LVEDD), and left atrium diameter (LAD). Secondary outcomes were systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), glomerular filtration rate (GFR), and creatinine. Seven studies were included in this analysis. From baseline to 6 months after RDN, the pooled mean NYHA class was decreased (mean difference [MD], -0.9; 95% confidence interval [CI], -1.6 to -0.2; P = 0.018), the mean 6-min walk test was increased (MD, 79.5 m; 95% CI, 26.9 to 132.1; P = 0.003), and the average NT-proBNP level was decreased (MD, -520.6 pg/mL; 95% CI, -1128.4 to 87.2; P = 0.093). Bilateral RDN increased the LVEF (MD, 5.7%; 95% CI, 1.6 to 9.6; P = 0.004), decreased the LVESD (MD, -0.4 cm; 95% CI, -0.5 to -0.2; P < 0.001), decreased the LVEDD (MD, -0.5 cm; 95% CI, -0.6 to -0.3; P < 0.001), and decreased the LAD (MD, -0.4 cm; 95% CI, -0.8 to 0; P = 0.045). In addition, RDN significantly decreased systolic BP (MD, -9.4 mmHg; 95% CI, -16.3 to -2.4; P = 0.008) and diastolic BP (MD, -4.9 mmHg; 95% CI, -9.5 to -0.4; P = 0.033), and decreased HR (MD, -4.5 bpm; 95% CI, -8.2to -0.9; P = 0.015). RDN did not significantly change GFR (MD, 7.9; 95% CI, -5.0 to 20.8; P = 0.230), or serum creatinine levels (MD, -7.2; 95% CI, -23.7 to 9.4; P = 0.397). Bilateral RDN appears safe and well-tolerated in patients with HF. RDN improved the signs and symptoms of HF and slightly decreased systolic and diastolic BP without affecting renal function in the clinical trials performed to date.

1 May 2017 in Autonomic Neuroscience
Verified
Journal Article
Closed access
ASAlicia M. Schiller
Alicia M. Schiller
PPPeter Ricci Pellegrino
Peter Ricci Pellegrino
IZIrving H. Zucker
Irving H. Zucker

11 October 2023 in Journal of Surgical Oncology
Verified
Journal Article
Open access
PPPeter Ricci Pellegrino
Peter Ricci Pellegrino
MAMadhuri Are
Madhuri Are
Among patients undergoing surgical oncologic operations, patients in low‐ and middle‐income countries are at particularly high risk for inadequate perioperative analgesia. This article reviews some of the guiding pillars of pain management for cancer surgery, including use of regional analgesia and acute pain service consultation, multimodal adjunctive analgesia, and judicious opioid use while presenting data on international disparities for each pillar and proposing strategies to address these inequities.

1 July 2025 in Hypertension
Verified
Journal Article
Closed access
PPPeter Ricci Pellegrino
Peter Ricci Pellegrino
IZIrving H. Zucker
Irving H. Zucker
YCYiannis S. Chatzizisis
Yiannis S. Chatzizisis
HWHANJUN WANG
HANJUN WANG
ASAlicia Schiller
Alicia Schiller
BACKGROUND: The field of renal denervation remains challenged by the inability to confirm successful ablation of the targeted renal sympathetic nerves. The availability of technology to measure regional blood flow in real-time makes sympathetic control of the renal vasculature a logical end point to assess effective renal denervation, but autoregulatory mechanisms mask effects on mean renal blood flow. We hypothesized that renal sympathetic vasomotion, a novel marker of rhythmic sympathetic control, reflects successive rounds of catheter-based radiofrequency renal denervation. METHODS: To test this, 10 pigs underwent unilateral surgical renal denervation, recovered for at least 7 days, and then underwent 4 successive rounds of catheter-based radiofrequency denervation of the contralateral kidney. Bilateral renal blood flow velocity and abdominal aortic pressure were measured before and after ablations to calculate renal vasomotion. RESULTS: Before catheter-based denervation, the renal vasomotion profiles of the innervated and surgically denervated kidneys differed significantly ( P <0.005). Ablation of the largest renal branch artery reduced renal sympathetic vasomotion by 52%. Ablation of the remaining renal branch arteries reduced sympathetic vasomotion by 95% from baseline and eliminated the statistical differences between surgically and catheter-denervated kidneys. Two additional rounds of catheter denervation of the main renal artery did not consistently decrease the renal sympathetic vasomotion magnitude any further. CONCLUSIONS: These results indicate that renal sympathetic vasomotion could provide intraprocedural feedback for interventionalists performing catheter-based renal denervation and thereby improve the efficacy, safety, and consistency of this antihypertensive intervention.

15 January 2015 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Open access
PDF file
PPPeter R. Pellegrino
Peter R. Pellegrino
ASAlicia M. Schiller
Alicia M. Schiller

23 October 2025 in bioRxiv
Verified
Preprint
Open access
JHJuan Hong
Juan Hong
SGSamuel Gillman
Samuel Gillman
PPPeter Pellegrino
Peter Pellegrino
GZGang Zhao
Gang Zhao
RRRongguo Ren
Rongguo Ren
HWHANJUN WANG
HANJUN WANG
Summary: The cardiac sympathetic afferent reflex (CSAR) and pulmonary spinal afferent reflex (PSAR) amplify sympathetic outflow, and their sensitization contributes to chronic heart failure (CHF). Using a myocardial infarction (MI) rat model, molecular profiling, imaging, and functional assays revealed that thoracic dorsal root ganglia (DRGs) undergo marked macrophage and glial activation and suppression of voltage-gated potassium (Kv) channels after MI. In vitro studies confirmed that pro-inflammatory cytokines and activated macrophages directly reduce Kv channel expression and activity in DRG neurons. Cardiac afferents mediated cytokine transport from the heart to DRGs, driving macrophage infiltration in a cytokine receptor-dependent manner. Anti-inflammatory strategies including systemic minocycline, liposomal clodronate–induced macrophage depletion, or local epidural dexamethasone prodrug delivery reduced neuroinflammation, restored Kv channel levels, attenuated the exaggerated CSAR and PSAR, and improved cardiac remodeling. These findings highlight a cytokine uptake–driven inflammatory pathway in cardiopulmonary spinal afferent sensitization and support targeted DRG anti-inflammatory therapy as a potential cardioprotective approach. The cardiac sympathetic afferent reflex (CSAR) and pulmonary spinal afferent reflex (PSAR) amplify sympathetic activity and may contribute to chronic heart failure (CHF). We hypothesized that neural inflammation in thoracic dorsal root ganglia (DRGs) drives cardiopulmonary afferent sensitization through suppression of voltage-gated potassium (Kv) channels after myocardial infarction (MI). MI was induced in rats by coronary ligation. Molecular profiling, immunofluorescence, tissue clearing, and functional assays were used to assess neuroinflammation and reflex responses. Post-MI, thoracic DRGs showed macrophage infiltration, glial activation, cytokine upregulation, and reduced Kv channel expression. Bulk RNA-seq identified enrichment of macrophage activation–related genes, and in vitro studies confirmed that pro-inflammatory cytokines and activated macrophages suppressed Kv channels and increased DRG neuron excitability. Epicardial injection of biotinylated TNF-α demonstrated cardiac afferent–mediated cytokine transport to DRGs, inducing macrophage infiltration via a cytokine receptor-dependent mechanism. Anti-inflammatory interventions including oral minocycline, systemic macrophage depletion, and local epidural delivery of thermo-responsive hydrogel-forming dexamethasone prodrug (ProGel-Dex) significantly reduced DRG neuroinflammation, restored Kv channel levels, and attenuated exaggerated CSAR and PSAR responses. ProGel-Dex also improved cardiac chamber dilation in the post-MI rats. These findings identify a cytokine uptake–glial activation– macrophage activation pathway as a driver of cardiopulmonary afferent sensitization after MI. Targeting DRG inflammation, particularly with sustained local dexamethasone delivery using ProGel-Dex, offers a precision medicine to dampen pathological sympathetic activation and improve cardiac outcomes in CHF. Highlights: Both cardiac (CSAR) and pulmonary (PSAR) spinal afferent reflexes are sensitized after myocardial infarction, contributing to sympathetic overactivation. Thoracic dorsal root ganglia (T1–T4) exhibit macrophage activation, glial responses, pro- inflammatory cytokine upregulation, and suppression of Kv channels following MI. Cardiac afferents mediate receptor-dependent uptake and transport of cytokines (e.g., TNF-α) from the heart to DRGs, driving macrophage infiltration and inflammation. Activated macrophages and pro-inflammatory cytokines reduce Kv channel expression and Kv current density (Ito) in DRG neurons, enhancing excitability. Anti-inflammatory strategies including minocycline, liposomal clodronate–induced macrophage depletion, and local epidural dexamethasone prodrug attenuate neuroinflammation, restore Kv channel expression, and suppress exaggerated CSAR/PSAR. Targeting DRG inflammation, particularly via sustained epidural dexamethasone delivery, represents a promising cardioprotective precise medicine.